Methylene blue sentinel lymph node biopsy for breast cancer learning curve in the COVID-19 era: How many cases are enough?

Background: Sentinel lymph node biopsy (SLNB) is now the gold standard for early breast cancer with clinically negative lymph nodes (N0). According to the Indonesian Board-Certified oncologist surgeon, the learning curve for evaluating fellow breast surgeons to achieve this competency could have bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Azhar, Yohana, Dewayani, Birgitta M., Lukman, Kiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521048/
https://www.ncbi.nlm.nih.gov/pubmed/37767080
http://dx.doi.org/10.12688/f1000research.122408.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521048/
https://www.ncbi.nlm.nih.gov/pubmed/37767080
http://dx.doi.org/10.12688/f1000research.122408.2

Ejemplares similares